Om Megashree Pharmaceuticals to Issue IPO from Falgun 27

Om Megashree Pharmaceuticals Limited is set to issue 1,476,000 IPO shares to the general public from Falgun 27. The company's total capital is NPR 600 million, of which 30% (1.8 million shares) will be issued. In the first phase, 180,000 shares have already been allocated to Nepali citizens working abroad, while 54,000 shares are reserved for employees and 90,000 for mutual funds.

The IPO price is set at NPR 100 per share, with a minimum application of 10 shares and a maximum of 10,000 shares. The deadline for applications is Chaitra 3, but if not fully subscribed, it will be extended until Chaitra 12.

Prabhu Capital Limited is the IPO issue manager. Applications can be submitted through ASBA-approved banks, financial institutions, and the Mero Share online platform.

Located in Bharatpur-29, Chitwan, Om Megashree Pharmaceuticals will be the first pharmaceutical company to be listed on the Nepal Stock Exchange (NEPSE). The project’s total cost is NPR 1.26 billion, with NPR 975.4 million already spent. The estimated payback period is 7.15 years.